2010
DOI: 10.1371/journal.pgen.1001029
|View full text |Cite
|
Sign up to set email alerts
|

Ancestry-Shift Refinement Mapping of the C6orf97-ESR1 Breast Cancer Susceptibility Locus

Abstract: We used an approach that we term ancestry-shift refinement mapping to investigate an association, originally discovered in a GWAS of a Chinese population, between rs2046210[T] and breast cancer susceptibility. The locus is on 6q25.1 in proximity to the C6orf97 and estrogen receptor α (ESR1) genes. We identified a panel of SNPs that are correlated with rs2046210 in Chinese, but not necessarily so in other ancestral populations, and genotyped them in breast cancer case∶control samples of Asian, European, and Afr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

13
83
3

Year Published

2011
2011
2019
2019

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 86 publications
(99 citation statements)
references
References 38 publications
13
83
3
Order By: Relevance
“…Our findings with 6q25.1-rs3734805 and 6q25.1-rs9383938 are consistent with the GWAS study on breast cancer where these variants were first reported (28) and with a subsequent case-control study of 6q25.1 (55). A meta-analysis of five GWAS of MD within the Marker Of DEnsity (MODE) consortium, examined 23 of the established breast cancer variants with MD and reported a significant association of rs2046210 -ESR1 and MD (18).…”
Section: Consistency and Inconsistency Of Overall Findings With Previsupporting
confidence: 87%
“…Our findings with 6q25.1-rs3734805 and 6q25.1-rs9383938 are consistent with the GWAS study on breast cancer where these variants were first reported (28) and with a subsequent case-control study of 6q25.1 (55). A meta-analysis of five GWAS of MD within the Marker Of DEnsity (MODE) consortium, examined 23 of the established breast cancer variants with MD and reported a significant association of rs2046210 -ESR1 and MD (18).…”
Section: Consistency and Inconsistency Of Overall Findings With Previsupporting
confidence: 87%
“…The inability to replicate associations with the index signals despite adequate statistical power (.70% power for 12 of 19 variants) suggests that they are unlikely to be functional variants or capture the functional variants as efficiently in this population. Our ability to find associated markers in five regions where index signals were not significantly associated with risk also demonstrates the value of testing common variation at GWAS-identified risk loci in additional populations (14,16,17,22,37,38).…”
Section: Discussionmentioning
confidence: 76%
“…We tested the 19 validated breast cancer risk variants (referred as "index variants") at 1p11, 2q35, 3p24, 5p12, 5q11, 6q25, 8q24, 9p21, 9q31, 10p15, 10q21, 10q22, 10q26, 11p15, 11q13, 14q24, 16q12, 17q23 and 19p13 in models adjusted for age, study, global ancestry (the first 10 eigenvectors) and local ancestry; 5,[12][13][14][15][16][17] 17 SNPs were directly genotyped, while 2 were imputed using MACH (r 2 >0.98). All 19 variants were common (≥0.05) in African Americans, with 11 variants being more common in Europeans than African Americans.…”
Section: Chromosome 20q11mentioning
confidence: 99%
“…Recently, three genome-wide association studies (GWASs) have revealed that three single-nucleotide polymorphisms (SNPs; rs3757318, rs2046210, and rs3734805) near or in the ESR1 gene are associated with breast cancer (Zheng et al, 2009;Turnbull et al, 2010;Fletcher et al, 2011). However, the results of replication studies were not consistent owing to the sample sizes used and the diverse genetic backgrounds of the ethnic groups involved (Stacey et al, 2010;Zhong and Prentice, 2010;Campa et al, 2011).…”
Section: Introductionmentioning
confidence: 99%